Valuation: Boston Scientific Corporation

Market Cap 61.45B 54.55B 51.05B 46.27B 87.38B 5,923B 88.01B 613B 238B 3,022B 231B 226B 9,714B P/E 2026 *
16x
P/E 2027 * 16.8x
Enterprise Value 70.18B 62.29B 58.3B 52.84B 99.79B 6,765B 101B 700B 272B 3,451B 263B 258B 11,094B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-0.59%
1 week-4.07%
Current month-3.56%
1 month-6.41%
3 months-5.62%
6 months-32.74%
Current year-55.85%
1 week 41.94
Extreme 41.9397
43.97
1 month 41.94
Extreme 41.9397
47.45
Current year 41.94
Extreme 41.9397
100.9
1 year 41.94
Extreme 41.9397
105.65
3 years 41.94
Extreme 41.9397
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 2011-10-31
Director of Finance/CFO 52 2025-06-29
Chief Tech/Sci/R&D Officer - 2009-08-31
Director TitleAgeSince
Chairman 61 2016-05-02
Director/Board Member 74 2014-02-28
Director/Board Member 74 2016-04-14
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 Buy

Director

2,040 0.0001%
8/11/26 Other

Controller/Auditor

2,930 0.0002%
8/10/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-0.63%-4.07%-56.47%-19.23% 61.45B
-2.84%-3.13%+21.04%+32.06% 250B
-2.47%-4.48%+2.02%-0.58% 156B
-0.20%-1.65%-9.85%+37.10% 144B
-1.43%-1.99%+12.76%+17.14% 50.28B
+1.66%-1.50%-21.21%-19.75% 46.73B
-1.11%-3.36%+19.44%+52.88% 48.29B
+0.14%+1.81%-5.39%+35.31% 45.89B
-1.18%-1.29%+33.55%+63.62% 43.24B
-7.01%+1.08%+172.17%+96.36% 44.35B
Average -1.50%-1.29%+16.80%+29.49% 88.96B
Weighted average by Cap. -1.74%-2.24%+11.38%+26.10%

Financials

2026 *2027 *
Net sales 21.19B 18.81B 17.6B 15.96B 30.13B 2,043B 30.35B 211B 82.23B 1,042B 79.54B 77.84B 3,350B 22.28B 19.78B 18.51B 16.78B 31.69B 2,148B 31.92B 222B 86.48B 1,096B 83.65B 81.85B 3,523B
Net income 3.79B 3.36B 3.15B 2.85B 5.39B 365B 5.42B 37.79B 14.7B 186B 14.22B 13.91B 599B 3.67B 3.26B 3.05B 2.76B 5.22B 354B 5.26B 36.61B 14.24B 180B 13.77B 13.48B 580B
Net Debt 8.73B 7.75B 7.25B 6.57B 12.41B 841B 12.5B 87.08B 33.87B 429B 32.76B 32.06B 1,380B 5.49B 4.88B 4.56B 4.14B 7.81B 530B 7.87B 54.82B 21.32B 270B 20.63B 20.18B 869B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
26-10-06 US$42.07 -0.78% 8,009,464
26-10-05 US$42.40 -0.47% 13,744,303
26-10-02 US$42.60 -1.46% 18,313,943
26-10-01 US$43.23 -0.96% 17,937,780
26-09-30 US$43.65 -0.52% 17,967,900
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
42.40USD
Average target price
60.62USD
Spread / Average Target
+42.97%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation